chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day 2: 102 fever lasted 20 hours, chills, body twitches, arm pain, headache severe (1-10 scale at 10) vision blurriness, extreme fatigue ..  The weekend after the shot : random feeling of what felt like a rush of cold water or air over head, followed by dizziness and nausea, followed by vision blur. Swollen lymph nodes, moderately swollen on neck, random episodes of shortness of breath lasting 5-10min and increased heart rate. Also noticed heat flashes at random times, itchiness at lymph node sites, itchy throat, (avoided inhaler due to increased Heart rate)  Following week same things but occurring more often, disorientation and short term memory loss . Contacted primary MD to screen for more info . Never had any of these problems or symptoms ever in my life , EVER. My vision has always been 2020, it?s my pride, my memory has always been excellent I take great pride in that too, I haven?t been SICK in years?my immune system is strong and I have had no need for my inhaler or any other meds in several years. This may sound small but is very abnormal  for me which makes it  an extremely huge deal
After the vaccination I became lightheaded and dizzy which lasted all that day and into the 23rd.  I developed a headache on the 23 also but by the 24th I felt just fine.
pt had shrill cry, t104 24 hrs p/vax; pt seen in ER & given PO APAP & sponge bathed & refered to regular MD: 20NOV92 dx as virus;
Information has been received through a pregnancy registry from a 29 year old female with no pertinent medical history and no drug reactions/allergies who on 1/11/05 was vaccinated with a dose of MMR and a tuberculin purified protein derivative shot. On 2/10/05, she was vaccinated with a 0.5ml dose of varicella virus vaccine live and a diphtheria toxoid (+) tetanus toxoid shot. There was no other concomitant medication. On 2/10/05, she became pregnant. No medical attention was sought. There were no laboratory diagnostic studies performed. There was no product quality complaint. Follow up information received from the patient indicated that she had an abortion. She indicated that she did not want to take any risk for the baby. No additional information is expected.
Lot of gas; Bloating; Very nauseus; Lost appetite; This spontaneous case was reported by a physician and describes the occurrence of DECREASED APPETITE (Lost appetite), FLATULENCE (Lot of gas), ABDOMINAL DISTENSION (Bloating) and NAUSEA (Very nauseus) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]) and OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced DECREASED APPETITE (Lost appetite) and NAUSEA (Very nauseus). On 25-Jan-2021, the patient experienced FLATULENCE (Lot of gas) and ABDOMINAL DISTENSION (Bloating). At the time of the report, DECREASED APPETITE (Lost appetite), FLATULENCE (Lot of gas), ABDOMINAL DISTENSION (Bloating) and NAUSEA (Very nauseus) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
I had hives arrive on my hand/fingers and also bottom of my heels and toes.  They itched and were irritated for about 5 days and then slowly went away.  I had made no other changes to any detergents, soap, shampoo etc anywhere around this time.
The patient's right thigh was red, hot and swollen. A raised area, oval in shape,with the measurements of 1" long X 1/2 wide was noted. Throughout the night, she was lethargic and irritable. This morning, the mother was instructed to give 0.8 ml of Infants tylenol. The first dose is suppose to be given at 9:15 A.M. , with a subsequent doses at 12:15. Warm compresses were also to be applied to the area.
Patient called this morning to report she had fallen ill after receiving the flu shot. Patient reported cough and SOB that had both improved since yesterday.
I developed a mild-moderate case of COVID, characterized by initial cold-like symptom of runny nose and scratchy throat. I  then developed more congestion and a cough. I recieved medical care x2 via telehealth with Dr. He was helpful in letting me know what to watch for.  He prescribed Tessalon for my cough, which was helpful.  I also took Musinex DM and Musinex, spending on my cough. I was sick with COVID for about a week, tested negative on day 9.  I have fully recovered and have no health concerns or symptoms.
Narrative:  46yo male pt who had received a covid vaccine on 3/18/2021 (J&J) at unknown place died on 8/20/21 of unknown causes. Pt had NEVER been seen at clinic. No information on patient medical hx. Not able to assess if covid vaccine is related to pt's death. Likely death is not related to covid vaccines given death was past 90 days since vaccine admin date.
Pt recv vax on 3/4/99; 4 hr post vax pt exp seizure-like activity, vomiting, eye deviation, tension} <30 sec..more vomit, lethargy/ sleepy
tender; severe pain in arm; hard nodule about 4 inches down from injection site; fatigue; nausea; flushing feverish; injection site is red; little achiness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tender), PAIN IN EXTREMITY (severe pain in arm), VACCINATION SITE INDURATION (hard nodule about 4 inches down from injection site), FATIGUE (fatigue) and NAUSEA (nausea) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TENDERNESS (tender), PAIN IN EXTREMITY (severe pain in arm), VACCINATION SITE INDURATION (hard nodule about 4 inches down from injection site), FATIGUE (fatigue), NAUSEA (nausea), PYREXIA (flushing feverish), VACCINATION SITE ERYTHEMA (injection site is red) and INJECTION SITE PAIN (little achiness at injection site). At the time of the report, TENDERNESS (tender), PAIN IN EXTREMITY (severe pain in arm), VACCINATION SITE INDURATION (hard nodule about 4 inches down from injection site), FATIGUE (fatigue), NAUSEA (nausea), PYREXIA (flushing feverish), VACCINATION SITE ERYTHEMA (injection site is red) and INJECTION SITE PAIN (little achiness at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products and treatment medication were provided by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-064112 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-064112:
L arm at injection site red, whelped (7" long, 5 1/2 " wide), itches, hot to touch. Shot received at pharmacy.
felt bad; Stuck in bed; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad) and MALAISE (Stuck in bed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) unknown. On 28-Feb-2021, the patient experienced FEELING ABNORMAL (felt bad) and MALAISE (Stuck in bed). At the time of the report, FEELING ABNORMAL (felt bad) and MALAISE (Stuck in bed) outcome was unknown.            No concomitant medications or treatment details reported.   This case was linked.
RECEIVED HALF DOSE FOR THEIR BOOSTER DOSE; OFF LABEL USE; This spontaneous report received from a health care professional concerned a 30 year old female of unspecified race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously vaccinated with covid-19 vaccine ad26. cov2. s (dose number in series 1) (unspecified manufacturer) (suspension for injection, route of administration, and batch number were not reported) dose was not reported for prophylactic vaccination. No adverse events were reported following administration of covid-19 vaccine ad26. cov2. s (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of administration not reported, lot number: 211A21A (also reported as: 1822809), expiry: unknown), 1 total administered on 27-NOV-2021 for prophylactic vaccination (dose number in series 2). No concomitant medications were reported.  On 27-NOV-2021, the patient had received a half dose for their booster dose (captured: Vaccine underdose) and off label use (dose number series 2). As described by reporter, HCP (health care provider) (from health dept) stated that there were 33 patients who received half doses (0.25ml (milliliter)) for their booster or 3rd dose a few days ago. Most of them were patients from Texas. HCP stated that something was printed and disseminated that said to administer .25ml. HCP was not sure where that information came from. Stated it was over the holidays so people could have thought that info changed and staff was just not made aware. HCP did not think it had been reported yet through VAERS (vaccine adverse event reporting system). HCP thought that the vendor will file the report with VAERS, not public health department. HCP stated that they figured it out after the event because they could not figure out how so many doses were given. They were looking for a discrepancy in the number of vials perhaps, but then realized that half doses were given. HCP consented to being contacted, but stated that she may not be the best person to contact. If she had an alternate contact she would provide it to whomever reached out to her. The reporter went on to report that HCP stated that Spartan is the vendor. At the time of the discussion they were both teaming up together to gather information and they may have called to report these events as well, so HCP warned to be mindful of possible duplicate reports. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of received half dose for their booster dose and off label use was not reported. This report was non-serious. This case, from the same reporter is linked to 20211202250, 20211201046, 20211201082, 20211201228, 20211201168, 20211200752, 20211201351, 20211200994, 20211201450, 20211202199, 20211202469, 20211201286, 20211204104, 20211202193, 20211201228, 20211202469, 20211165041, 20211202371, 20211202246, 20211202207, 20211201443, 20211201392, 20211201362, 20211201304, 20211201179, 20211201179, 20211200723, 20211200717, 20211200675 and 20211165041.
This spontaneous report has been received from a nurse referring a patient of an unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 05-DEC-2018, the patient was vaccinated with an expired date dose of VARIVAX, lot # M039317 expiration date 20-SEP-2018 and also with an expired dose of VAQTA, lot # N028743 expiration date 23-NOV-2018, for prophylaxis (Expired product administered). No adverse effects were reported.
Patient obtained her 1st dose of the Moderna vaccine on May 22nd subsequent development erythema roughly 4 fingers below the injection site, roughly 24 hours after the injection.  Notes associated swelling, warmth and discomfort.  Denies any open wound, fevers, chills or malaise. Since then, erythema and swelling have progressed by increasing roughly 1 cm in diameter. Notes pruritus and discomfort have improved by the time of today's (5/27/21) clinic visit.  She has tried no medications or topicals to treat the rash. No additional sites of rash.  She denies syncope, lightheadedness, dizziness, lip swelling, tongue swelling, shortness of breath, wheezing, abdominal pain, nausea, vomiting.  No PEG allergy history. No documented vaccine allergies. No allergies causing anaphylaxis.
8/21/04: pt bit by bat on tip of left index finger. Started rabies vaccine 8/25/04 as well as givenn rabies Immunoglobulin. Given subsequent rabies vaccines on 8/27, 9/1, 9/14, 9/24. On 9/24/04, pt reports bad taste in mouth since starting vaccines.
cough; lost her sense of taste and smell; lost her sense of taste and smell; muscle weakness; fever of 102 degrees; Vomiting; muscles are not working; clear drainage; Feels like she has either sinus or the flu; felt outside of her body; Feels like she has either sinus or the flu; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, lot number: EN6202 and expiration date: May2021) via an unspecified route of administration in arm right on 11Mar2021 (age at vaccination 63 year) as single for COVID-19 immunization. Medical history included adult-onset mitochondrial myopathy from 2000. Concomitant medications included hydrochlorothiazide, lisinopril 12.5 mg for blood pressure from 2018 and sertraline 100 mg for depression. Patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, lot number: EL9264) via an unspecified route of administration in arm right on 18Feb2021 (age at vaccination 63 year) as single dose for COVID-19 immunization and experienced shoulder pain. On 12Mar2021, the patient experienced cough, vomiting, lost her sense of taste and smell, muscle weakness, fever of 102 degrees, felt outside of her body, felt like she has either sinus or the flu, her muscles are not working. On an unspecified date in Mar2021, the patient experienced clear drainage. On 12Mar2021, the patient underwent lab tests and procedures which included body temperature 102. Seriousness of the events were unspecified. The outcome of the events cough, lost her sense of taste and smell, muscle weakness, fever of 102 degrees, vomiting, muscles are not working was not recovered. The outcome of the events felt outside of her body, felt like she has either sinus or the flu was unknown. On an unspecified date in Mar2021, clear drainage resolved.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No follow-up attempts are needed. No further information is expected.
Early menstruation approximately 10 days early. Due to having PCOS, I have never had an early period in life, only "regular" or very late, usually skipping multiple months at a time. Also it is very heavy and painful compared to my regular period. I am also feeling dizzy.
ITCHY RIGHT AWAY  -Today is 2-5-15. On Jan 17 to now. Dry painful eyes, severe stiffness in back and stomach and bloat. Shoulder pain, muscle tremors and muscle spasms in legs move to arms stomach back and neck. My BP up and down as well as sugar -BP low as 100/50. Always cold but low temp. No blood work has been conclusive of what is the issue. I have never had these issues -I work out every day. This has halted me to a stop for 2 weeks. My muscle hurt so bad in groin legs and back stomach when even attempting one hour of cardio and no weights.
Pt developed a red, swollen and hot area at vaccine site post 48 hours approx 10 cm x 7 cm. Applied hot compress and oral Benadryl. Resolved in 24 hours.
Temperature excursion - CDC recommend Re-vax. Pt revaccinated on 11/02/2021.
Initial information received on 18-Sep-2018 regarding an unsolicited valid non-serious case received from other health professional (pharmacy student). This case involves a 33 years old female patient who was vaccinated with a 0.5 ml dose of FLUZONE HIGH DOSE (lot: UJ006AA; expiry date: 14-Apr-2019) in the right deltoid on an unknown date. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was a case of actual medication error due to inappropriate age at vaccine administration. It was not reported whether the patient had experienced any adverse events or not. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
soreness at the injection site; A spontaneous report was received from a Consumer concerning a 60 Years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced injection site pain.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 28 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 028L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 29 Jan 2021, the patient experienced the event soreness at the injection site.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   At the time of this report, the outcome of event, soreness at the injection site was unknown..; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
This is a spontaneous report from a contactable physician via a Pfizer sales representative. A male patient of an unspecified age and ethnicity received TRUMENBA, via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced high fever, chills, headache, and flu-like symptoms for 24 hours after receiving the first dose of meningococcal group b rlp2086. Outcome of the events was unknown.
haven't felt good all day; I woke up this morning chilling; have a fever of 101; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (haven't felt good all day), CHILLS (I woke up this morning chilling) and PYREXIA (have a fever of 101) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (haven't felt good all day), CHILLS (I woke up this morning chilling) and PYREXIA (have a fever of 101). At the time of the report, MALAISE (haven't felt good all day), CHILLS (I woke up this morning chilling) and PYREXIA (have a fever of 101) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  No concomitant medications reported. No treatment reported.
Passing out at work.. Syncope...  high heart rate... extremely low blood pressure.... dizziness... headaches... fatigue
This is a spontaneous report from a contactable consumer. This  consumer reported similar events for two patients. This is the first of two reports. A female patient of an unspecified age and ethnicity received PREVNAR13 via an unspecified route of administration on an unspecified date. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced numbness to the arm and neck and shoulder on one side, metallic taste in the mouth, eyes burning, and ears feeling like they are under water on an unspecified date. The outcomes of the events, numbness in the arm and neck and shoulder on one side, metallic taste in the mouth, eyes burning, and ears feeling like they are under water were unknown. Follow-up (26FEB2015): No follow up attempts possible. No further information expected.
Felt "crummy" after the second shot; This is a spontaneous report from a non-contactable consumer. A patient of unspecified age and gender received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  Historical Vaccine BNT162B2 Dose number 1 COVID-19 immunisation. On an unspecified date the patient experienced felt "crummy" after the second shot. Outcome of the event was recovered on unspecified date.   No follow-up attempts needed. No further information is expected
11/1/07. Initially had lower back pain and left arm pain. Following day low-grade fevers and chills x 24 hrs followed by pain/weakness in both thighs interfering with walking and achy, sharp pain in both forearms with bilateral hand weakness. Muscle weakness and pain interfered with his ability to walk, climb stairs, brush teeth, open a can, button a shirt and writing. No double vision, chewing difficulty, swallowing or shortness of breath. Muscle weakness and pain progressed. Saw PCP 11/5/07 who referred patient to neurologist r/o Guillain-Barre syndrome secondary to influenza vaccine. 11/6/07 evaluated by Neurologist who concluded patients' clinical presentation and EPS findings (Needle EMG & Nerve Conduction)are suggestive of AIDP aka Guillain-Barre Syndrome. Neurologist recommended outpatient IVIG therapy, serum testing for Lyme titers, TSH, Campylobacter jejuni titers, vitamin B12 level and IgA level. After IVIG therapy, Physical Therapy for muscle strengthening and gait training is recommended.  11/14/2007 296557 -per nurse- pt has received flu vax for the past 5yrs with no reaction. Used different manufacturer this year. 11/19/2007 MR received from neurologist for OV of 11/06/2007.  Pt presented with progressive muscle weakness x 3 days.  Pt first noted back pain and L arm pain with low grade fever and chills.  Pt then noted pain in thighs which interfered with walking and ability to climb stairs.  Achy sharp pain noted in forearms and weakness in hands bilat.  Difficulty with ADLs noted.  PE (+) for muscle weaknes in extremities bilat.  DTRs are decreased in arms and legs.  Sensation decreased in stocking-glove distribution bilat.  Mild walking difficulty. Txd with IVIG, PT and gait training. DX: Guillain-Barre Syndrome (AIDP). 1/19/2010 Able to ADL effortlessly. Continues to have muscles weakness and fatigue in legs and to lesser extent his arms.
lethargic , nausea, arm pain  body aches, fever lasted 3 days swollen lymph nodes under left arm and severe pain  lasted for 4 days
Intense pain in the L/leg. Went to ER, where they performed an ultrasound that showed a large blood clot in that leg. A subsequent CT scan revealed a small blood clot in the R/lung. Was given Lovenox and later Eliquis. Admitted to hospital same day.